NNews Read More SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment2026-08-19 SELLAS’s lead therapy, galinpepimut-S, is in a Phase 3 study called REGAL for patients with acute myeloid leukemia…
